09-09-2022 17:15-18:15 Track 4

Invited Session

Topic: Medical Retina

AI in Retinal Diseases

Chair(s): Paisan Ruamviboonsuk (Thailand); Sebastian Waldstein (Austria);

Detection of DR from Ultra-Widefield Scanning Laser Ophthalmoscope Images: A Multicenter Deep Learning Analysis
Sobha Sivaprasad (United Kingdom)
The current and future status of AI in Retina
Sebastian Waldstein (Austria)
AI to Stratify Severity of AMD and Predict Risk of Progression to Late AMD
Tiarnan Keenan (United States)
Deep learning to detect OCT-derived DME from retinal photographs: a multicenter validation study
Paisan Ruamviboonsuk (Thailand)
The UK perspective on digital health and AI in retina disease
Dawn Sim (United Kingdom)
Deep Learning for the Diagnosis of Stage in ROP: Accuracy and Generalizability across Populations and Cameras
Peter Campbell (United States)

11-09-2022 13:30-14:30 Track 1

Invited Session

Topic: Medical Retina

Choroid

Chair(s): Taiji Sakamoto (Japan); Jay Chhablani (India);

Anomalies of choroidal venous structures in high myopia
Kyoko Ohno-Matsui (Japan)
Changes in Haller Vessel and Choriocapillaris using SS-OCT angiography in Diabetic Choroidopathy
Hyewon Chung (South Korea)
Choroidal vasculature 3D modeling
Jay Chhablani (India)
Central Serous Chorioretinopathy
Francine Behar-Cohen (France)
Choroidal imaging
Shozo Sonoda (Japan)

12-09-2022 16:00-17:00 Track 1

Invited Session

Topic: Medical Retina

Inherited Retinal Diseases: State of the art in diagnosis and treatment- Instructional Course

Chair(s): Carlos Mendoza (United States); Juliana Sallum (Brazil);

IRD: Clinical diagnosis
Carlos Mendoza (United States)
Molecular diagnosis
Juliana Sallum (Brazil)
Multimodal Imaging in Inherited Retinal Degenerations. Past and Present
Ramiro Maldonado (United States)
ERG
Rodrigo Matsui Serrano (Mexico)
Current treatment
Byron Lam (United States)

09-09-2022 13:30-14:30 Track 3

Invited Session

Topic: Medical Retina

Latest Developments in Retinal Diseases

Chair(s): Rufino Silva (Portugal); Paolo Lanzetta (Italy);

Going the Distance: Longer-Duration Treatments for Wet AMD
Christina Y. Weng
Update on Diabetic Macular Edema Treatments
Diana Do (United States)
Coming up management options in Geographic atrophy
Arshad M. Khanani (United States)
Addressing the safety issues with long duration treatments
Caroline Baumal (United States)
Functional and morphological methods for monitoring patients on long interval treatments
Tunde Peto (Ireland)
Emerging therapies for Stargardt disease
Hendrik Scholl (Switzerland)

12-09-2022 19:45-20:45 Track 1

Invited Session

Topic: Medical Retina

New insights in the pathogenesis and progression of age-related chorio-retinal degeneration

Chair(s): Taiji Sakamoto (Japan); Anat Loewenstein (Israel);

Treatment-naive quiescent vs non-exudative MNVs
Francesco Bandello (Italy)
Basal laminar deposits: a common finding in reticular pseudodrusen
Ricardo Sacconi (Italy)
The aging choroid
Srinivas Sadda (United States)
Subclinical age-related angioid streaks with pseudodrusen - a frequent cause of AMD misdiagnosis
Giuseppe Querques (Italy)
Predicting progression of age-related macular degeneration using artificial intelligence
Zhichao Wu (Australia)

10-09-2022 12:15-13:15 Track 1

Invited Session

Topic: Medical Retina

Retinal Vein Occlusion - Instruction Course

Chair(s): Sharon Fekrat (United States);

The Top 5 findings from the SCORE2 Study
Michael Ip (United States)
Retinal Vein Occlusion (RVO) and Systemic Medicine
Alan Cruess (Canada)
Lessons learned from radial optic neurotomy for CRVO
Jorge Rocha (Brazil)

11-09-2022 21:00-22:00 Track 1

Invited Session

Topic: Medical Retina

Systemic Medications and Retinal Toxicity - Instructional Course

Chair(s): William F. Mieler (United States); Francisco Rodriguez;

Retina pigmentary changes
William F. Mieler (United States)
Checkpoint inhibitors: Good and Bad
Carol Shields (United States)
Pentosan polysulfate
David Sarraf (United States)
Tamoxifen
Lihteh Wu (Costa Rica)

09-09-2022 10:00-23:00 Virtual

ICO Member Society: Hellenic Ophthalmological Society

Topic: Medical Retina

Current and future developments in Diabetic Retinopathy

Chair(s): Irini Chatziralli (Greece);

Diabetic retinopathy as a microvascular complication of diabetes: New insights into pathophysiology and target for treatment
Panagiotis Malamos (Greece)
The management of DME and PDR in 2022
Alexandros Charonis
Diabetes and vitreoretinal interface disorders: Challenges and new horizons
Petros Petrou (Greece)
Diabetic Retinopathy: The “glaucoma specialist” perspective
Stylianos Kandarakis (Greece)

10-09-2022 11:00-12:00 Track 4

ICO Member Society: The Ophthalmological Society of Taiwan

Topic: Medical Retina

Current status of Inherited retinal disease in Taiwan

Chair(s): San-Ni Chen (Taiwan, China); Chang-Hao Yang (Taiwan, China);

Genotypes and phenotypes of Inhertied retinal degeneration
Chi-Hsien Peng (Taiwan, China)
Recent advances in inherited retinal degeneration
Shun-Ping Huang (Taiwan, China)
Advanced stem cell-based therapeutics in retinal degenerative diseases
Shih-Hwa Chiou (Taiwan, China)
Exploring the population-based genetic characteristics & Real-world experience of gene therapy for inherited retinal degeneration in Taiwan
Ta-Ching Chen (Taiwan, China)

09-09-2022 10:00-23:00 Virtual

ICO Member Society: EuroLam Retina

Topic: Medical Retina

Management of infrequent cases of vitreoretinal diseases

Chair(s): Francesco Bandello (Italy); David Pelayes (Argentina);

Surgical treatment of a Massive Choroidal Detachment associated with RRD as a complication of a Cataract Surgery.
Jesus H Gonzalez-Cortes (Mexico)
Retinal Detachment in Wagner-Stickler Syndrome.
Rene Cano (Mexico)
Carlevale scleral fixated IOL. The ultimate solution.
Stratos Gotzaridis (Greece)
Management of Exudative Retinal Detachment in Coats Disease.
Faisal Fayyad (Jordan)
A case of bilateral endogenous endophthalmitis.
Federico Graue (Mexico)

12-09-2022 11:00-12:00 Track 4

ICO Member Society: Russian Ophthalmology Society

Topic: Medical Retina

Russian Opthalmology Society symposium

Chair(s): Boris Malyugin (Russian Federation);

Features of anti-VEGF therapy for vascularized retinal pigment epithelium detachments in patients with AMD
Maria Budzinskaia (Russian Federation)
Antivasoproliferative therapy for submacular hemorrhages
Rinat Fayzrakhmanov (Russian Federation)
Comprehensive evaluation of vascular disorders in active retinopathy of prematurity
Irina Trifanenkova (Russian Federation)
Preeclampsia as one of the possible causes of the development of vascular retinal pathology
Oleg Kolenko (Russian Federation)
Navigated micropulse laser for the treatment of central serous chorioretinopathy
Pavel Volodin (Russian Federation)
The role of noninvasive multimodal imaging in planning navigated laser therapy
Dmitrii Maltsev (Russian Federation)

09-09-2022 19:45-20:45

ICO Member Society: The Macula Society

Topic: Medical Retina

The Macula Society Symposium

Chair(s): ;

Giant Tears of the Internal Limiting Membrane: Prevalence, Clinical Characteristics, and Surgical Utility
Mark Johnson (United States)
Paladin study
Michael Singer
Expedited Intervention Strategy for Retinal Artery Occlusions - Creating A Successful Metropolitan EyeStroke Network
Richard Rosen (United States)
Combined surgical techniques to repair refractory macular holes
Peiquan Zhao (People's Republic of China)
Real-world management of AI-based retinal fluid quantification in neovascular AMD
Ursula Schmidt-Erfurth (Austria)
Update on Intrvitreal Anti-VEGF therapies for Exudative AMD
Susanna Park

09-09-2022 10:00-23:00 Virtual

On-Demand

Topic: Medical Retina

Medical Retina Free Paper Session IV

Chair(s): ;

Key Pearls of the Refill-Exchange Procedure for the Port Delivery System With Ranibizumab (PDS)
Adrian Fung (Australia)
Faricimab in Neovascular Age-Related Macular Degeneration: 48-Week Results by Dosing Cohort in the Phase 3 TENAYA/LUCERNE Trials
Stephan Michels (Switzerland)
Brolucizumab for the Treatment of Diabetic Macular Edema: 52-week Results from the KINGFISHER Study
Andres Emanuelli (Puerto Rico)
Efficacy and safety of biosimilar QL1207 vs aflibercept for neovascular age-related macular degeneration (nAMD): a phase 3 trial
TBA
Real World Efficacy, Durability and Safety of Faricimab in Diabetic Macular Edema: The TAHOE Study
Tyler Ewing (United States)
Eight-year visual acuity outcomes of the Treat-and-Extend Regimen in Management of Neovascular Age-related Macular Degeneration
Rodney Fong (United States)
Safety and Efficacy of Intravitreal Conbercept in China: A Long-term, Prospective, Multi-center and Real-World Study (STONE STUDY)
Xinyuan Zhang (People's Republic of China)

09-09-2022 10:00-23:00 Virtual

On-Demand

Topic: Medical Retina

Medical Retina Free Papers Session III

Chair(s): ;

Does retinal vascularization progress after 60 weeks postmenstrual age in infants treated with bevacizumab?
Sadik Etka Bayramoglu (Turkey)
Artificial Intelligence for Screening of Multiple Retinal Diseases: A Real-world, Multicenter Study
Li Dong (People's Republic of China)
Risk of ischemic stroke and hemorrhagic stroke in retinal vein occlusion: A nationwide Population-Based Cohort study
Yu-Yen Chen
Unsupervised Domain Adaptation with Self-selected Active Learning for Cross-domain OCT Image Segmentation
Tingting Liu (Hong Kong, China)
The Efficacy And Safety of Conbercept Ophthalmic Injection For Macular Edema Secondary to Central Retinal Vein Occlusion (CRAVE)
Xuehui Shi (People's Republic of China)
Various Phenotypes of Autosomal Dominant Cone-Rod Dystrophy with CRX Mutation in Two Chinese Families
Hui Cui (People's Republic of China)